Pharming Group excels with RUCONEST and JOENJA, showing strong revenue growth and positive cash flow. Check out my recommendation for PHAR stock.

The filing with the EMA comes a few weeks after Pharming filed leniolisib for approval in the US, setting up potential approvals for what would be the Netherlands-based biotech's second product on ...

Abliva AB is a biotechnology company focused on developing ... This was further complemented by a public cash offer from Pharming Technologies B.V. to acquire all shares in Abliva, which was ...

A live webcast and replay of the presentation will be available in the “Upcoming Events” and “News” sections of Pharming’s website. For more information about these conferences ...

The deal also included a clause giving Novartis the right to purchase the PRV from Pharming “for a pre-agreed, contractually defined percentage of the PRV value,” said the Dutch biotech in a ...

Leiden, the Netherlands, March 4, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today that the Extraordinary General Meeting of ...